Literature DB >> 21975051

Virus interference. Did rhinoviruses activity hamper the progress of the 2009 influenza A (H1N1) pandemic in Norway?

Gabriel Ånestad1, Svein Arne Nordbø.   

Abstract

During summer and autumn 2009 Norway, like several other European countries, experienced an unexpected delay in the progress of the 2009 pandemic influenza A (H1N1) virus. It is considered whether interference with other respiratory viruses, in particular rhinoviruses, may have hampered the development of the influenza pandemic, and if interference phenomena are common in the development of outbreaks with epidemic viruses. If so, cytokines, in particular interferon, are the most probable executor of this effect.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21975051     DOI: 10.1016/j.mehy.2011.09.021

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  26 in total

1.  Attenuation of Influenza A Virus Disease Severity by Viral Coinfection in a Mouse Model.

Authors:  Andres J Gonzalez; Emmanuel C Ijezie; Onesmo B Balemba; Tanya A Miura
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

2.  Assessment of Virus Interference in a Test-negative Study of Influenza Vaccine Effectiveness.

Authors:  Shuo Feng; Ashley L Fowlkes; Andrea Steffens; Lyn Finelli; Benjamin J Cowling
Journal:  Epidemiology       Date:  2017-07       Impact factor: 4.822

3.  Outbreak of Influenza and Other Respiratory Viruses in Hospitalized Patients Alongside the SARS-CoV-2 Pandemic.

Authors:  Ilana S Fratty; Shira Reznik-Balter; Ital Nemet; Nofar Atari; Limor Kliker; Hilda Sherbany; Nathan Keller; Michal Stein; Ella Mendelson; Michal Mandelboim
Journal:  Front Microbiol       Date:  2022-06-13       Impact factor: 6.064

4.  Increased risk of rhinovirus infection in children during the coronavirus disease-19 pandemic.

Authors:  Emi Takashita; Chiharu Kawakami; Tomoko Momoki; Miwako Saikusa; Kouhei Shimizu; Hiroki Ozawa; Makoto Kumazaki; Shuzo Usuku; Nobuko Tanaka; Ichiro Okubo; Hiroko Morita; Shiho Nagata; Shinji Watanabe; Hideki Hasegawa; Yoshihiro Kawaoka
Journal:  Influenza Other Respir Viruses       Date:  2021-03-14       Impact factor: 4.380

5.  Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine.

Authors:  Benjamin J Cowling; Vicky J Fang; Hiroshi Nishiura; Kwok-Hung Chan; Sophia Ng; Dennis K M Ip; Susan S Chiu; Gabriel M Leung; J S Malik Peiris
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

6.  Respiratory viruses in hospitalized children with influenza-like illness during the h1n1 2009 pandemic in Sweden [corrected].

Authors:  Samuel Rhedin; Johan Hamrin; Pontus Naucler; Rutger Bennet; Maria Rotzén-Östlund; Anna Färnert; Margareta Eriksson
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

7.  Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.

Authors:  Nagarjuna R Cheemarla; Timothy A Watkins; Valia T Mihaylova; Bao Wang; Dejian Zhao; Guilin Wang; Marie L Landry; Ellen F Foxman
Journal:  J Exp Med       Date:  2021-06-15       Impact factor: 17.579

8.  Intense co-circulation of non-influenza respiratory viruses during the first wave of pandemic influenza pH1N1/2009: a cohort study in Reunion Island.

Authors:  Hervé Pascalis; Sarah Temmam; Magali Turpin; Olivier Rollot; Antoine Flahault; Fabrice Carrat; Xavier de Lamballerie; Patrick Gérardin; Koussay Dellagi
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

9.  Capacity and adaptations of general practice during an influenza pandemic.

Authors:  Kristian A Simonsen; Steinar Hunskaar; Hogne Sandvik; Guri Rortveit
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

10.  Rhinovirus Reduces the Severity of Subsequent Respiratory Viral Infections by Interferon-Dependent and -Independent Mechanisms.

Authors:  James T Van Leuven; Andres J Gonzalez; Emmanuel C Ijezie; Alexander Q Wixom; John L Clary; Maricris N Naranjo; Benjamin J Ridenhour; Craig R Miller; Tanya A Miura
Journal:  mSphere       Date:  2021-06-23       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.